Cargando…
Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
CONTEXT: Patients with serotonin-secreting neuroendocrine neoplasms (NENs) have increased serum 5-hydroxyindoleacetic acid (5HIAA) concentrations. Serum 5HIAA thus serves as a biomarker in NEN. OBJECTIVE: To evaluate an improved tandem mass spectrometric serum 5HIAA assay for diagnosis and follow-up...
Autores principales: | Becker, Anna, Schalin-Jäntti, Camilla, Itkonen, Outi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237842/ https://www.ncbi.nlm.nih.gov/pubmed/34195530 http://dx.doi.org/10.1210/jendso/bvab106 |
Ejemplares similares
-
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
por: Gedde-Dahl, Merete, et al.
Publicado: (2013) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020) -
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
por: Formica, V, et al.
Publicado: (2007) -
Serum 5-Hydroxyindoleacetic Acid and Ratio of 5-Hydroxyindoleacetic Acid to Serotonin as Metabolomics Indicators for Acute Oxidative Stress and Inflammation in Vancomycin-Associated Acute Kidney Injury
por: Lee, Hyun-Seung, et al.
Publicado: (2021) -
5-Hydroxyindoleacetic acid, a new ligand for GPR35, plays an important role in inflammatory disease: 5-Hydroxyindoleacetic acid in inflammatory disease
por: Yang, Zhisheng, et al.
Publicado: (2022)